Latest News

EC approves Janssen nasal antidepressant spray

The European Commission (EC) has approved Spravato (esketamine) nasal spray, in combination with a selective serotonin reuptake inhibitor (SSRI) or serotonin and norepinephrine reuptake inhibitor (SNRI) for adults living with treatment-resistant major depressive disorder (TRD), Janssen has announced.

This story continues at EC approves Janssen nasal antidepressant spray

Or just read more coverage at Irish Medical Times

Source link

Related posts

Developing less aggressive cancer drugs that enable the immune system to recognize tumors


2018/19 Applications of Advanced Visualization in Healthcare –


Experts treat severe, disfiguring sarcoidosis with novel therapy


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy